Terrier, Benjamin

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science

interferon and immune responsesCOVID-19 Clinical Research Studies

Cited by 2,984

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Zhang, Q., Bastard, P., Liu, Z., Le Pen, J., Moncada-Velez, M., Chen, J., Ogishi, M., Sabli, I. K. D., Hodeib, S., Korol, C., et al. (2020) · Science

interferon and immune responsesSARS-CoV-2 and COVID-19 Research

Cited by 2,229

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial

Hermine, O., Mariette, X., Tharaux, P.-L., Resche-Rigon, M., Porcher, R., Ravaud, P., CORIMUNO-19 Collaborative Group, Bureau, S., Dougados, M., Tibi, A., et al. (2021) · JAMA Internal Medicine

COVID-19 Clinical Research StudiesRespiratory Support and Mechanisms

Cited by 734

Ocular Safety Profile of BRAF and MEK Inhibitors

Mettler, C., Monnet, D., Kramkimel, N., Tréluyer, J.-M., Mouthon, L., Brézin, A., Dupin, N., Valnet-Rabier, M.-B., Chouchana, L., & Terrier, B. (2021) · Ophthalmology

Drug-Induced Ocular ToxicityPharmacovigilance and Adverse Drug Reactions

Cited by 40

Physiopathologie de la granulomatose éosinophilique avec polyangéite (Churg-Strauss)

Chaigne, B., Dion, J., Guillevin, L., Mouthon, L., & Terrier, B. (2016) · La Revue de Médecine Interne

Vasculitis and related conditionsEosinophilic Disorders and Syndromes

Cited by 6